FULC
Fulcrum Therapeutics Inc.
Company Overview
| Mkt Cap | $540.92M | Price | $8.75 |
| Volume | 662.24K | Change | +1.74% |
| P/E Ratio | -55.6 | Open | $8.59 |
| Revenue | $80.0M | Prev Close | $8.60 |
| Net Income | $-9.7M | 52W Range | $2.32 - $10.11 |
| Div Yield | N/A | Target | $12.21 |
| Overall | 55 | Value | 60 |
| Quality | 47 | Technical | 60 |
No chart data available
Stock Overview
Updated DailyFulcrum Therapeutics Inc. (FULC) is a leading Manufacturing company in the Medicinal and Botanical Manufacturing industry, currently trading at $8.75 with a market capitalization of $540.92 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows FULC with a volume of 662K shares. The stock opened down 0.12% from yesterday's close of $8.60. Current analyst estimates project earnings of $-1.15 per share for this year, with next year targeting $-1.22.
FULC demonstrates strong technical indicators based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for FULC include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 39.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:03 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FULC | $8.75 | +1.7% | 662.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Fulcrum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW